| Tag | Content |
|---|
EnhancerAtlas ID | HS091-19456 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr17:34202650-34205150 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NR2C2 | MA0504.1 | chr17:34204819-34204834 | TGACCTCTGACCTCT | - | 8.73 | | Nr2f6 | MA0677.1 | chr17:34204819-34204833 | TGACCTCTGACCTC | - | 7.42 | | Rxra | MA0512.2 | chr17:34204819-34204833 | TGACCTCTGACCTC | - | 6.88 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_16790 | chr17:34201942-34203749 | CD4_Naive_Primary_8pool | | SE_16790 | chr17:34203837-34208370 | CD4_Naive_Primary_8pool | | SE_20595 | chr17:34202046-34205149 | CD56 | | SE_22836 | chr17:34201798-34208788 | CD8_primiary |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH17I035875 | chr17 | 34202243 | 34204446 | | GH17I035877 | chr17 | 34204872 | 34204994 |
|
Enhancer Sequence | GAAGTCAAAA GGCCAGGAAA ACAATACCTG AGATGAGGGT AGCTCAGGCC TCCATTTCCT 60
GCCCCCAACC TCCCCGCAGA CTGTGATACC AAAGAACAGC CCCTCCTTGC CAAGTCTTCC 120
CTCCTTACCT CCATTTTTGG CACCCTCTGC TTGCCTGACT TCCTCCTTCT GCCTACCCCT 180
TAAGAGCGGA TGTTCTCAAA GCTGCTGCCC TTTTCTCTTC TTTGCGTTTT TTCCTAAGTC 240
TCTGGCCCTG GGCCTGGCAC ATAGTTGATG CTTAATGGAT GTTTATTGAA TGATTAAGTG 300
AATGAATGCA ATTCACTCAT TCATTCCTTA AGTTTCACCT GTTATTTTTG TGTACGCAAT 360
AATGCATTTA GATGATAATG ATAATAATAA GCTAACATTT ATGCACCTAC TGTGTACCAG 420
AGCATATTCT AAGTATTTTC ATCTTACTGT GACCCAGTGG GGGAAGTACT TCTATTACCC 480
TATTTTGTAG AGGAGGTAAT TGGGGTTACG AGAGGTTAAT TGAAGGGCCT ACACTCACCA 540
AGTGTCATAG CTGGAGTCCT AACAAAGCAA ACTAGCTCTA GAGCCAGTAC TCACCAAGGC 600
AGGCTGCATT GCCTTTTTAA AATTGGGATA CCCCTTTTTC CCACAAAAGA ATGTCATATT 660
TTCAGCCCTA ACACCCTTTC CTCAGCTACC AACCCTTCAT TTCACCATCA CCACTGGACA 720
TATCCACAGG GTTATCTTGC TGGCACCTTA GCTCTTTCCT CTTTAAACAG CTCTTTCACA 780
AGGCTTAAGA TGGTTCTACA CTTCTCCAGC CAGAGGTGGA AACCTCAGTG TCATCCTTAA 840
CCCCCATTTT TCTCCCTTGC TCTTGAGCTC AAATCACCTG CTAGGGCTTG CAAATTCCAC 900
CTTTGAAGGT TTCAAAAGTG TCTGTCTTTG AAACCTCCTG TCTCTCCTTT CCTTCAGGCA 960
CTGTTCAGCC TCCAATACTA CTCACGTGGA TAACAACAGT AGCCGCTAAA CTGGACTCCT 1020
GTTTTCTCAG CTTTCCCTGT TCTAGCTCAT TTTACACTTG ACAGCTGCAT TTAGCACTTT 1080
TGCTGCATTT TCCTGACACT CCGTGCTTTC CTACATGGAG ACTGTACATA AACCAAAGTA 1140
GAATCCTGGG GGACAGTCCC TTTTCCTGAT ATATCCCATT CCCTAGGCTT TTCTCTGCCA 1200
GGCCAAATCT CTCCTCAGAC AGCACCATTT GCAGCAAACC TGTAAATCCC TGAAGCTGAA 1260
TGTGTTTCCT CTCTCTTTCC CTTGTCATGT TTTTTTTTGC TGTGTACTCT AGTCATTGCT 1320
GTGTCTGTCT TGCCCCTCTT ATTAGACTAT GAGTCCCATA AGGTTGGGCT GGGACAGTGG 1380
CTTTAGTAAT CTGTGTCTGC CAATAGTATG TGCTCAGGGA AGGATTTTCT TCTTTTGAAA 1440
AATATTTGTT TTCAGAAATA AAATTAGTAA TTGTTAAATA TTACCATTAT ACTTAAAAGG 1500
ATTCATCAGA TCCAAAGTCT GTCTTTGAGT ACCTCTAACT TTGCCAGTGT CATAAATTTT 1560
TGGATTAAAA AACTTCACCC TGGCTGGGTA CAGTAGCTCA CACCTGTAAT CCCAGCACTT 1620
TAGGAGGCTG AGGCAAGAGA ATTGCTTGAA CCCGGGAGGC AAAGGATGCA GTGAGCTGAG 1680
ATTGCACCAT TGTACTCCAG CCTGGGCAAC AGAGTGAGTG AGACTCTGTC TCAAAACAAA 1740
AACAAAAACA AAAACTTCAC TCTTATATAA GAAACTTCAG AATTGCACCA TTTTCATTTT 1800
TTAAGTCTCT ACCATAAATT TCTTAAGCAA TTGTCACTAA TGACTTTGCT ATAGTAGAAA 1860
GAGGAGGCTC TAGAGATGGA CTTCATCCCT CATTTACTGT GCAGCCTTGG CTAAATCAAT 1920
AAACCTCTCT GAATCTTAGT TTCAATACCT GAAACATGGA GAGAATTATG CATACTTGTC 1980
AGAGCTAAGT GTAATTTAAA GATCAGGCAC ATAAGACATT TGACACATAG TAGGCATTTC 2040
CTATATAGTA GGGTTTATTA TATTTTTCCA AATATACTAG CTTGCATATT TAAAGGTGAA 2100
TCTCATTTCC TTATTTCTTC TCTGATGGAT GGCTTTTTGT TTTTTTATTT GACTACAGTT 2160
ATAGATCCCT GACCTCTGAC CTCTTCTCCC TAGTTCCTCT GAGGTTTAGG TGGATTTGAT 2220
TGGGTGTGAA ATATGGGGGA CTGTGTGAAA TATGGGGTTC TTCACTGAAG GGGATGACTG 2280
ACTTGATCTT CCCCACATAG GAGCATTCCA GACCATGTTT CAAGTAAAGG CCACACTAGT 2340
AAAGATTGGA GTCCTAGGCC AGGCACAGTG GCTCATGCCT ATAATCCCAG CACTTTGGGA 2400
GGCTGAGGCG GGTAGATCAC GAGGGCAGGA GATCGAGACC ATCCTGGCTA ACACGGTGAA 2460
ACCCCGTCTC TACTAAAAAT ACAAAAAATT AGCCAGGCAT 2500
|
